Christopher Tovey
Chief Executive Officer at DESTINY PHARMA PLC
Profile
Currently, Christopher John Tovey is Chief Operating Officer at GW Pharmaceuticals Plc. He is also on the board of CanImGuide Therapeutics AB, GW Research Ltd. and GW Pharma Ltd. Mr. Tovey previously occupied the position of Director-Vaccines Business Unit at GlaxoSmithKline Plc and Vice President-Global Marketing Operations at UCB SA. He received an undergraduate degree from The University of Liverpool.
Christopher Tovey active positions
Companies | Position | Start |
---|---|---|
DESTINY PHARMA PLC | Chief Executive Officer | 2023-08-31 |
GW Research Ltd.
GW Research Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Jazz Pharmaceuticals Plc, Jazz Pharmaceuticals Research UK Ltd. is a private company that engages in researching and developing biotechnology. Jazz Pharmaceuticals Research UK Ltd. is based in Cambridge, UK. Founded in 1995. | Director/Board Member | 2012-09-30 |
CanImGuide Therapeutics AB
CanImGuide Therapeutics AB Pharmaceuticals: MajorHealth Technology CanImGuide Therapeutics AB develops cancer therapies. The firm is a biotechnological company that reverses cancer related immunosuppression. It manufactures the proprietary drug P28R, a peptide with two modes of actions. The company was founded on March 21, 2006 and is headquartered in Hollviken, Sweden. | Director/Board Member | - |
GW Pharma Ltd.
GW Pharma Ltd. Pharmaceuticals: MajorHealth Technology Part of Jazz Pharmaceuticals Plc, GW Pharma Ltd. is a British pharmaceutical company that manufactures pharmaceutical products. The private company is based in Histon, UK. GW Pharma was founded in 1999. | Director/Board Member | 2012-09-30 |
Former positions of Christopher Tovey
Companies | Position | End |
---|---|---|
JAZZ PHARMACEUTICALS PLC | Chief Operating Officer | 2022-09-30 |
GW PHARMACEUTICALS PLC | Chief Operating Officer | - |
UCB | Corporate Officer/Principal | 2012-08-31 |
GSK PLC | Corporate Officer/Principal | 2004-12-31 |
Training of Christopher Tovey
The University of Liverpool | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 4 |
---|---|
GSK PLC | Health Technology |
UCB | Health Technology |
DESTINY PHARMA PLC | Health Technology |
JAZZ PHARMACEUTICALS PLC | Health Technology |
Private companies | 4 |
---|---|
GW Pharmaceuticals Ltd.
GW Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology GW Pharmaceuticals Ltd. operates as an intermediate holding company and management company for investments in its subsidiaries. The company was founded by Geoffrey William Guy and Brian Whittle in 1998 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
CanImGuide Therapeutics AB
CanImGuide Therapeutics AB Pharmaceuticals: MajorHealth Technology CanImGuide Therapeutics AB develops cancer therapies. The firm is a biotechnological company that reverses cancer related immunosuppression. It manufactures the proprietary drug P28R, a peptide with two modes of actions. The company was founded on March 21, 2006 and is headquartered in Hollviken, Sweden. | Health Technology |
GW Research Ltd.
GW Research Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Jazz Pharmaceuticals Plc, Jazz Pharmaceuticals Research UK Ltd. is a private company that engages in researching and developing biotechnology. Jazz Pharmaceuticals Research UK Ltd. is based in Cambridge, UK. Founded in 1995. | Commercial Services |
GW Pharma Ltd.
GW Pharma Ltd. Pharmaceuticals: MajorHealth Technology Part of Jazz Pharmaceuticals Plc, GW Pharma Ltd. is a British pharmaceutical company that manufactures pharmaceutical products. The private company is based in Histon, UK. GW Pharma was founded in 1999. | Health Technology |
- Stock Market
- Insiders
- Christopher Tovey